Arthritis

Australian researchers perform "target trial emulation" to compare popular drugs

Randomized study finds no disparities in biologics prescribing, but questions linger

New "points to consider" document lists early warning signs

Novel agent adds additional action in hopes of improving efficacy

Of three major prognostic tools, none hit the mark

Familiar biologic halts progression in high-risk patients with just a few painful joints

In separate studies, one old standby and one newer biologic appeared helpful

Health news and commentary from around the Web gathered by MedPage Today staff

A 52-year-old woman presented to the doctor with left anterior ankle pain and foot swelling, decreased range of motion, and gait disturbance that had developed steadily over the past 4-6 weeks. Can you diagnose the patient?

Exact mechanism remains speculative, however

Members unimpressed with efficacy, safety data

Advisory committee to consider novel product in Thursday meeting

A look at Horizon Therapeutics' tactics

Analysis looked at patients with stage 1-3 CKD from the MIRROR trial